Publications by authors named "Stacy L Toriola"
Article Synopsis
- The standard treatment for chronic cutaneous sarcoidosis is corticosteroids, but when these are ineffective, other treatment options like monoclonal antibody therapies become necessary.
- This systematic review examined recent clinical studies focusing on interventions such as tumor necrosis factor-alpha (TNF-α) and Janus kinase (JAK) antibody therapies for patients whose sarcoidosis did not respond to corticosteroids.
- Of the 16 studies reviewed, 15 showed improvement in skin lesions within two weeks to 18 months; however, anti-TNF-α treatments had notable adverse effects, while anti-JAK-STAT treatments had no reported adverse events despite smaller patient samples.
